Barron's says a legal challenge to the much-reviled Sarbanes-Oxley legislation, if successful, could have widespread implications: "Stocks initially might soar because SarbOx imposes significant costs on publicly traded companies. Afterwards, however, the markets might have second thoughts: Congress could make the law even tougher." And then there's investor mistrust.